168 related articles for article (PubMed ID: 33239129)
21. Impact of Obesity on Voriconazole Pharmacokinetics among Pediatric Hematopoietic Cell Transplant Recipients.
Takahashi T; Smith AR; Jacobson PA; Fisher J; Rubin NT; Kirstein MN
Antimicrob Agents Chemother; 2020 Nov; 64(12):. PubMed ID: 32988816
[TBL] [Abstract][Full Text] [Related]
22. A pharmacokinetic comparison of two voriconazole formulations and the effect of CYP2C19 polymorphism on their pharmacokinetic profiles.
Chung H; Lee H; Han HK; An H; Lim KS; Lee YJ; Cho JY; Yoon SH; Jang IJ; Yu KS
Drug Des Devel Ther; 2015; 9():2609-16. PubMed ID: 25999694
[TBL] [Abstract][Full Text] [Related]
23. Correlation of CYP2C19 genotype with plasma voriconazole exposure in South-western Chinese Han patients with invasive fungal infections.
Miao Q; Tang JT; van Gelder T; Li YM; Bai YJ; Zou YG; Wang LL; Shi YY
Medicine (Baltimore); 2019 Jan; 98(3):e14137. PubMed ID: 30653146
[TBL] [Abstract][Full Text] [Related]
24. CYP2C19 Genotype-Dependent Pharmacokinetic Drug Interaction Between Voriconazole and Ritonavir-Boosted Atazanavir in Healthy Subjects.
Zhu L; Brüggemann RJ; Uy J; Colbers A; Hruska MW; Chung E; Sims K; Vakkalagadda B; Xu X; van Schaik RH; Burger DM; Bertz RJ
J Clin Pharmacol; 2017 Feb; 57(2):235-246. PubMed ID: 27432796
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the inhibition of human carboxylesterases (CESs) by the active ingredients from
Fu Q; Yang K; Hu RX; Du Z; Hu CM; Zhang X
Xenobiotica; 2019 Nov; 49(11):1260-1268. PubMed ID: 30486721
[TBL] [Abstract][Full Text] [Related]
26. Development of Physiology Based Pharmacokinetic Model to Predict the Drug Interactions of Voriconazole and Venetoclax.
Dong J; Liu SB; Rasheduzzaman JM; Huang CR; Miao LY
Pharm Res; 2022 Aug; 39(8):1921-1933. PubMed ID: 35725843
[TBL] [Abstract][Full Text] [Related]
27. A pharmacokinetic and pharmacodynamic study of drug-drug interaction between ginsenoside Rg1, ginsenoside Rb1 and schizandrin after intravenous administration to rats.
Zhan S; Guo W; Shao Q; Fan X; Li Z; Cheng Y
J Ethnopharmacol; 2014 Mar; 152(2):333-9. PubMed ID: 24462784
[TBL] [Abstract][Full Text] [Related]
28. Population pharmacokinetics of voriconazole and CYP2C19 polymorphisms for optimizing dosing regimens in renal transplant recipients.
Lin XB; Li ZW; Yan M; Zhang BK; Liang W; Wang F; Xu P; Xiang DX; Xie XB; Yu SJ; Lan GB; Peng FH
Br J Clin Pharmacol; 2018 Jul; 84(7):1587-1597. PubMed ID: 29607533
[TBL] [Abstract][Full Text] [Related]
29. Lignans from the fruits of Schisandra chinensis (Turcz.) Baill inhibit proprotein convertase subtilisin/kexin type 9 expression.
Pel P; Chae HS; Nhoek P; Yeo W; Kim YM; Chin YW
Phytochemistry; 2017 Apr; 136():119-124. PubMed ID: 28139296
[TBL] [Abstract][Full Text] [Related]
30. Chemical-pharmacokinetic-pharmacodynamic fingerprints of Schisandra chinensis alcoholic extract.
Wang BL; Hu JP; Sheng L; Chen H; Li Y
Yao Xue Xue Bao; 2013 May; 48(5):734-40. PubMed ID: 23888698
[TBL] [Abstract][Full Text] [Related]
31. Hepatoprotective Effects of Schisandra sphenanthera Extract against Lithocholic Acid-Induced Cholestasis in Male Mice Are Associated with Activation of the Pregnane X Receptor Pathway and Promotion of Liver Regeneration.
Zeng H; Li D; Qin X; Chen P; Tan H; Zeng X; Li X; Fan X; Jiang Y; Zhou Y; Chen Y; Wang Y; Huang M; Bi H
Drug Metab Dispos; 2016 Mar; 44(3):337-42. PubMed ID: 26658429
[TBL] [Abstract][Full Text] [Related]
32. Hepatic drug interaction between tacrolimus and lansoprazole in a bone marrow transplant patient receiving voriconazole and harboring CYP2C19 and CYP3A5 heterozygous mutations.
Iwamoto T; Monma F; Fujieda A; Nakatani K; Katayama N; Okuda M
Clin Ther; 2011 Aug; 33(8):1077-80. PubMed ID: 21802143
[TBL] [Abstract][Full Text] [Related]
33. Prediction of Drug-Drug Interaction between Tacrolimus and Principal Ingredients of Wuzhi Capsule in Chinese Healthy Volunteers Using Physiologically-Based Pharmacokinetic Modelling.
Zhang H; Bu F; Li L; Jiao Z; Ma G; Cai W; Zhuang X; Lin HS; Shin JG; Xiang X
Basic Clin Pharmacol Toxicol; 2018 Mar; 122(3):331-340. PubMed ID: 28945011
[TBL] [Abstract][Full Text] [Related]
34. Potent cytochrome P450 2C19 genotype-related interaction between voriconazole and the cytochrome P450 3A4 inhibitor ritonavir.
Mikus G; Schöwel V; Drzewinska M; Rengelshausen J; Ding R; Riedel KD; Burhenne J; Weiss J; Thomsen T; Haefeli WE
Clin Pharmacol Ther; 2006 Aug; 80(2):126-35. PubMed ID: 16890574
[TBL] [Abstract][Full Text] [Related]
35. [Intestinal absorption of the effective components of Schisandra chinensis Baill by rats single-pass perfusion in situ].
Chen XM; Li JS; Li W; Han L; Liu XH; Di LQ; Cai BC
Yao Xue Xue Bao; 2010 May; 45(5):652-8. PubMed ID: 20931771
[TBL] [Abstract][Full Text] [Related]
36. Impact of cytochrome P450 2C19 polymorphisms on the pharmacokinetics of tacrolimus when coadministered with voriconazole.
Imamura CK; Furihata K; Okamoto S; Tanigawara Y
J Clin Pharmacol; 2016 Apr; 56(4):408-13. PubMed ID: 26239045
[TBL] [Abstract][Full Text] [Related]
37. Hepato-protective effects of six schisandra lignans on acetaminophen-induced liver injury are partially associated with the inhibition of CYP-mediated bioactivation.
Jiang Y; Fan X; Wang Y; Tan H; Chen P; Zeng H; Huang M; Bi H
Chem Biol Interact; 2015 Apr; 231():83-9. PubMed ID: 25753323
[TBL] [Abstract][Full Text] [Related]
38. Impact of CYP2C19 Genotype and Drug Interactions on Voriconazole Plasma Concentrations: A Spain Pharmacogenetic-Pharmacokinetic Prospective Multicenter Study.
Blanco-Dorado S; Maroñas O; Latorre-Pellicer A; Rodríguez Jato MT; López-Vizcaíno A; Gómez Márquez A; Bardán García B; Belles Medall D; Barbeito Castiñeiras G; Pérez Del Molino Bernal ML; Campos-Toimil M; Otero Espinar F; Blanco Hortas A; Durán Piñeiro G; Zarra Ferro I; Carracedo Á; Lamas MJ; Fernández-Ferreiro A
Pharmacotherapy; 2020 Jan; 40(1):17-25. PubMed ID: 31782536
[TBL] [Abstract][Full Text] [Related]
39. The Pharmacokinetic Prediction of Cyclosporin A after Coadministration with Wuzhi Capsule.
Fan J; Chen L; Lu X; Li M; Zhu L
AAPS PharmSciTech; 2019 Jul; 20(6):247. PubMed ID: 31286321
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of neuroactive effects of ethanol extract of Schisandra chinensis, Schisandrin, and Schisandrin B and determination of underlying mechanisms by zebrafish behavioral profiling.
Wang JW; Liang FY; Ouyang XS; Li PB; Pei Z; Su WW
Chin J Nat Med; 2018 Dec; 16(12):916-925. PubMed ID: 30595216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
